Live Basket

Endpoint Catalyst Index

Equal-weight view of active Endpoint Arena clinical-trial readout markets, priced by live YES odds.

Last Refresh
Jun 29, 9:12 PM UTC
Basket Odds
35.5%

Equal-weight implied probability across active trial markets.

Move From Open
-6.8 pts

Started at 42.3% across the active basket.

Live Constituents
3

2 resolved markets kept out of the live basket.

Basket Volume
$3

8 trades across constituents.

Basket Odds
35.5%
Confidence Band
23%-47%
0%50%100%

Read-only research index. This is not an ETF, security, or offer to trade.

Sleeves
Immunology1 market
YES73.6%
Move+0.6 pts
Oncology1 market
YES0.0%
Move-22.0 pts
Other1 market
YES32.9%
Move+0.9 pts

Catalyst Calendar

Next active readout windows

Constituents

3 equal-weight markets

Sonelokimab in Psoriatic Arthritis
MLTXPhase 3NCT06641076
Week 16 ACR50 response versus placebo
Immunology
YES
73.6%
Move
+0.6
Weight
33.3%
Volume
$0
GPS Maintenance Therapy in AML Remission
SLSPhase 3NCT04229979
Overall survival for GPS versus best available therapy
Oncology
YES
0.0%
Move
-22.0
Weight
33.3%
Volume
$3
ABS-201 in Androgenetic Alopecia
ABSIPhase 1/Phase 2NCT07317544
Target Area Hair Count (TAHC)
Other
YES
32.9%
Move
+0.9
Weight
33.3%
Volume
$0